Health Highlights: Nov. 7, 2022
Amid a surge of RSV, hope for new vaccines. As many as four new RSV vaccine candidates could soon be sent for review by the U.S. Food and Drug Administration, experts say, and dozens more are in testing or under development. Read more
Is surgery always necessary for chronic chest pain? A new clinical trial finds patients' overall risk of death is about the same whether they choose aggressive surgical treatment or a more conservative approach focused on medication and lifestyle changes. Read more
Paxlovid might cut odds for long COVID. A new analysis showed people treated with the drug had a 26% reduced risk of developing several long COVID conditions, including heart disease, blood disorders, fatigue and other issues. Read more
Related Posts
COVAX Cuts Global COVID-19 Vaccine Supply Estimates by a Quarter
MONDAY, Sept. 13, 2021 (HealthDay News) -- Fewer COVID-19 vaccine doses than...
Muchos estadounidenses de clase media no podrán pagar una vivienda asistida
MIÉRCOLES, 7 de septiembre de 2022 (HealthDay News) -- Los adultos mayores de...
Exposing Kids to Safe Levels of Peanut When Young Might Prevent Allergy
FRIDAY, Jan. 21, 2022 (HealthDay News) -- Some kids might be able to get over...
Knee Replacement in Folks Over 80: Less Risky Than You Think
TUESDAY, March 22, 2022 (HealthDay News) -- Knee replacement surgery is...